3rd International Workshop on Liver and Gut Fibrosis

Name: 3rd International Workshop on Liver and Gut Fibrosis
Start: 2025-10-16T08:30:00+02:00
End: 2025-10-17T15:30:00+02:00
Location: ADEIT Fundación Universidad-Empresa de la Universitat de València

Schedule

Thu, 16 Oct, 2025 at 08:30 am to Fri, 17 Oct, 2025 at 03:30 pm

UTC+02:00

Location

ADEIT Fundación Universidad-Empresa de la Universitat de València | Valencia, VC

Fibrosis - the excessive growth of fibrous tissue due to chronic inflammation and altered tissue remodelling and repair processes - is a complex condition that affects millions worldwide, and the need for effective treatments and reliable diagnostic tools has never been more urgent. As it can affect various organs, fibrosis is a key component of numerous prevalent pathologies, including cystic fibrosis, Crohn’s Disease and Metabolic dysfunction-associated steatotic liver disease.
Despite the huge advances made by research in recent years, the molecular mechanisms involved in the development of fibrosis are still unclear and can differ in each of the affected organs. Importantly, there are few effective therapeutic options, and only for some organs, such as the lung and kidney, with no anti-fibrotic pharmacological treatments currently available for the intestine or liver.
The International Workshop on Liver and Gut Fibrosis is an initiative to bring together basic scientists and clinical experts working in the field to foster collaboration and advance our understanding of this condition. The workshop focuses on the molecular mechanisms involved in the different types of fibrosis, particularly on those that are common to different organs. In this way, we set out to explore avenues that might lead to an improvement of current therapeutic approaches and the identification of new pharmacological targets that could relieve the burden of fibrosis for millions of patients.
Following on from the first and second editions of this biannual workshop held in Valencia, on Spain’s Mediterranean coast, the 3rd edition will be a unique opportunity to engage with experts who are at the forefront of research to develop innovative anti-fibrotic therapies and identify new diagnostic tools that will bring significant transformations to patient care. We invite those of you with an interest in fibrosis to join us at Fundación Adeit on 16-17 October 2025 to continue exploring this increasingly relevant topic.